NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • IE • USD
Mallinckrodt plc (MNK) has a consensus analyst rating of Hold, based on 33 analysts covering the stock. Of those, 7 recommend buying, 21 recommend holding, and 5 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
